Congressional hearing examines concerns about oversight, abuse of 340B drug discount program

Posted on

Federal reports in recent years from Medicare advisory board, as well as GAO and OIG, have raised concerns about 340B program.

from Healthcarecare Finance News Feed http://www.healthcarefinancenews.com/news/congressional-hearing-examines-concerns-about-oversight-abuse-340b-drug-discount-program

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s